highperformr logo

Beam Therapeutics's Overview

Total employees535
HeadquartersCambridge
Founded2017

Beam Therapeutics (NASDAQ: BEAM) is a biotechnology company committed to establishing the leading, fully integrated platform for precision genetic medicines. The company's proprietary base editing technology enables a new class of genetic medicines that target a single base in the genome without making a double-stranded break in the DNA. Beam is focused on developing therapies for serious diseases with a broad portfolio of programs in hematology, immunology, oncology, and genetic diseases.

Where is Beam Therapeutics's Headquarters?

HQ Function

Serves as the central hub for corporate leadership, research and development, strategic planning, and administrative operations.

Notable Features:

Located in the heart of Kendall Square, a prominent biotech innovation hub, providing access to a rich ecosystem of talent and collaboration. Modern laboratory and office facilities designed to foster cutting-edge research.

Work Culture:

A dynamic, science-driven, and collaborative environment focused on innovation and making a difference in patients' lives. Emphasis on teamwork, scientific rigor, and a patient-centric approach.

HQ Significance:

The Cambridge HQ is strategically positioned to leverage the dense concentration of academic institutions, research organizations, and biotech companies in the Boston area, facilitating partnerships and talent acquisition.

Values Reflected in HQ: The state-of-the-art facilities and location in a leading innovation district reflect Beam's commitment to scientific excellence, innovation, and collaboration.

Location:

Beam Therapeutics' primary operations, including research, development, and manufacturing, are based in the United States (Cambridge, MA and Durham, NC). While they may engage in global clinical trials and collaborations with international partners and institutions to advance their gene editing therapies, their physical office and manufacturing footprint is currently concentrated in the US. Their therapeutic candidates, if successful, would aim for global impact on patients with serious diseases.

Street Address:

238 Main St

City:

Cambridge

State/Province:

MA

Country:

United States

Beam Therapeutics's Global Presence

Durham, North Carolina, United States

Address: 100 Resilience Way, Durham, NC 27703

Located in Research Triangle Park (RTP), a major hub for life sciences and biomanufacturing, providing access to specialized talent and infrastructure for scalable manufacturing.

Buying Intent Signals for Beam Therapeutics

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of Beam Therapeutics

As of April 2025, Beam Therapeutics' leadership includes:

John Evans - Chief Executive Officer
Suzanne Pond - Chief Business Officer and Head of Corporate Strategy
Amy Simon, M.D. - Chief Medical Officer
Christine Bellon, Ph.D., J.D. - Chief Legal Officer
Brian Riley - Chief Technical Operations Officer
Kate Walsh - Chief People Officer

Investors of Beam Therapeutics

Beam Therapeutics has been backed by several prominent investors over the years, including:

ARCH Venture Partners
F-Prime Capital Partners
GV (Google Ventures)
Redmile Group
Omega Funds
Logos Capital
RA Capital Management
EcoR1 Capital

Executive New Hires/Exits in the Last 12 Months

Hire0
Exits1

In the past 12 months, Beam Therapeutics saw a key departure with its President and Chief Scientific Officer. The CEO has assumed interim leadership of the research organization. No major external C-suite hires have been publicly announced during this period.

Departures

Giuseppe (Pino) Ciaramella, Ph.D., Departed from the company. CEO John Evans assumed interim leadership of research organization.

Technology (Tech Stack) used by Beam Therapeutics

Discover the tools Beam Therapeutics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Beam Therapeutics Email Formats and Examples

Beam Therapeutics likely utilizes common corporate email formats. Based on industry patterns and available data, one of the most probable formats is the first initial followed by the last name.

[first_initial][last]@beamtx.com

Format

jevans@beamtx.com

Example

80%

Success rate

News and media

Beam TherapeuticsMay 9, 2024

Beam Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates

Beam Therapeutics announced its Q1 2024 financial results, highlighting progress in its clinical programs, including BEAM-101 for sickle cell disease and BEAM-302 for alpha-1 antitrypsin deficiency. The company also provided updates on its pipeline and manufacturing capabilities....more

Beam TherapeuticsApril 8, 2024

Beam Therapeutics to Present New Preclinical Data from its In Vivo Base Editing Programs at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting

Beam announced upcoming presentations at ASGCT 2024, showcasing preclinical data for its in vivo base editing programs, including BEAM-302 for AATD and BEAM-301 for GSDIa....more

Beam Therapeutics SEC Filing (8-K)January 3, 2024

Beam Therapeutics Announces Departure of President and Chief Scientific Officer

Beam Therapeutics announced that Giuseppe Ciaramella, Ph.D., President and Chief Scientific Officer, departed from the company effective January 3, 2024. John Evans, Chief Executive Officer, assumed interim leadership of the company’s research organization....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Beam Therapeutics, are just a search away.